- 全部删除
您的购物车当前为空
Eliprodil (SL-820715) 是NR2B-NMDA 受体高效选择性抑制剂,IC50值1uM。它对NR2A-和NR2C-NMDA 受体作用较弱,可用于研究帕金森病和运动障碍治疗的试验。


为众多的药物研发团队赋能,
让新药发现更简单!
Eliprodil (SL-820715) 是NR2B-NMDA 受体高效选择性抑制剂,IC50值1uM。它对NR2A-和NR2C-NMDA 受体作用较弱,可用于研究帕金森病和运动障碍治疗的试验。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 5 mg | ¥ 162 | In stock | |
| 10 mg | ¥ 269 | In stock | |
| 25 mg | ¥ 535 | In stock | |
| 50 mg | ¥ 833 | In stock | |
| 100 mg | ¥ 1,290 | In stock | |
| 500 mg | ¥ 2,930 | In stock | |
| 1 mL x 10 mM (in DMSO) | ¥ 128 | In stock |
Eliprodil 相关产品
| 产品描述 | Eliprodil (SL-820715)(SL-820715), a non-competitive NR2B-NMDA receptor antagonist(IC50: 1 uM), less effective for NR2A- and NR2C-containing receptors(IC50> 100 uM). It has been used in trials studying the treatment of Parkinson Disease and Movement Disorders. |
| 靶点活性 | NR2B-NMDA:1 μM |
| 别名 | 依利罗地, SL-820715 |
| 分子量 | 347.85 |
| 分子式 | C20H23ClFNO |
| CAS No. | 119431-25-3 |
| Smiles | OC(CN1CCC(Cc2ccc(F)cc2)CC1)c1ccc(Cl)cc1 |
| 密度 | 1.205 g/cm3 |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||
| 溶解度信息 | DMSO: 6 mg/mL (17.25 mM), Sonication is recommended. | ||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||
DMSO
| |||||||||||||||||||||
评论内容